Abstract:Photodynamic therapy (PDT) brings new hope for the treatment of breast cancer due to few side effects and highly effective cell killing; however, the low bioavailability of traditional photosensitizers and their dependence on oxygen severely limits their application. Aggregation-induced emission (AIE) photosensitizers (PSs) can dramatically facilitate the photosensitization effect, which can have positive impacts on tumor PDT. To-date, most AIE photosensitizers lack tumor targeting capability and possess poor cell delivery, resulting in their use in large quantities that are harmful to healthy tissues. In this study, a series of AIE photosensitizers based on pyridinium-substituted triphenylamine salts (abbreviated to TTPAs 1 - 6 ) with different alkyl chain lengths are synthesized. Results reveal that TTPAs 1 - 6 promote the generation of type I and type II reactive oxygen species (ROS), including ·OH and 1 O 2 . In particular, the membrane permeability and targeting of TTPAs 4 - 6 bearing C8-C10 side-chains are higher than TTPAs 1 - 3 bearing shorter alkyl chains. Additionally, they can assemble with albumin, thereby forming nanoparticles (TTPA 4 - 6 NPs) in situ in blood, which significantly facilitates mitochondrial-targeting and strong ROS generation ability. Moreover, the TTPA 4-6 nanoparticles are pH-responsive, allowing for increased accumulation or endocytosis of the tumor and enhancing the imaging or therapeutic effect. Therefore, the in vivo distributions of TTPA 4 - 6 nanoparticles are visually enriched in tumor sites and exhibited excellent photodynamic cancer therapy efficacy. This work demonstrates a novel strategy for AIE PDT and has the potential to play an essential role in clinical applications using nano-delivery systems. Graphical A series of AIE photosensitizers assembling with albumin to form nanoparticles, which exhibits excellent ability of ROS generation. Additionally, these nanoparticles demonstrates outstanding tumor targeting and photodynamic cancer therapy effect. Download: Download high-res image (404KB) Download: Download full-size image

Recent Molecular Design Strategies for Efficient Photodynamic Therapy and Its Synergistic Therapy Based on AIE Photosensitizers

Progress and trends of photodynamic therapy: From traditional photosensitizers to AIE-based photosensitizers

Recent Advances in AIEgen‐Based Photodynamic Therapy and Immunotherapy

AIE-Active Photosensitizers: Manipulation of Reactive Oxygen Species Generation and Applications in Photodynamic Therapy

Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical

Photosensitizers with Aggregation‐Induced Emission: Materials and Biomedical Applications

Recent advances in aggregation-induced emission-active type I photosensitizers with near-infrared fluorescence: From materials design to therapeutic platform fabrication

Recent Progress in Type I Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy

Unusual Electron Donor-Acceptor Sequenced NIR AIEgen for Highly Efficient Mitochondria-Targeted Cancer Cell Photodynamic Therapy.

Aggregation-Induced Emission Luminogens for Enhanced Photodynamic Therapy: from Organelle Targeting to Tumor Targeting

Molecular Engineering to Boost AIE‐Active Free Radical Photogenerators and Enable High‐Performance Photodynamic Therapy under Hypoxia

Type I AIE photosensitizers: Mechanism and application

Designing NIR AIEgens for lysosomes targeting and efficient photodynamic therapy of tumors

Alkyl chain length-regulated in situ intelligent nano-assemblies with AIE-active photosensitizers for photodynamic cancer therapy

The AIE‐Active Dual‐Cationic Molecular Engineering: Synergistic Effect of Dark Toxicity and Phototoxicity for Anticancer Therapy

Trojan Horse‐Like Nano‐AIE Aggregates Based on Homologous Targeting Strategy and Their Photodynamic Therapy in Anticancer Application

Molecular Engineering of Efficient Singlet Oxygen Generators with Near‐Infrared AIE Features for Mitochondrial Targeted Photodynamic Therapy

Boost Highly Efficient Singlet Oxygen Generation and Accelerate Cancer Cell Apoptosis for Photodynamic Therapy by Logically Designed Mitochondria Targeted Near-Infrared AIEgens

AIEgens for synergistic anticancer therapy

Molecular Engineering to Achieve AIE-active Photosensitizers with NIR Emission and Rapid ROS Generation Efficiency

Rationally designed near-infrared AIEgens photosensitizer for cell membrane-targeted photo-driven theranostics